当前位置: 首页 > 期刊 > 《中外医疗》 > 2017年第25期
编号:13109137
呼出气一氧化氮检测对支气管哮喘患者的诊断及预后评估价值分析(3)
http://www.100md.com 2017年9月5日 《中外医疗》 2017年第25期
     [2] Ekerljung L,Bossios A,L■tvall J,et al. Multi-symptom asthma as an indication of disease severity in epidemiology[J]. Eur Respir J,2011,38(4):825-832.

    [3] 刘智艳.喘可治雾化吸入辅助治疗支气管哮喘临床疗效分析[J].中国当代医药,2012,19(21):103-104.

    [4] Kiljander TO,Junghard O,Beckman O,et al. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebocontrolled study[J].Am J Respir Crit Care Med, 2010,181(10):1042-1048.

    [5] Chanez P,Wenzel SE,Anderson GP,et al. Severe asthma in adults: what are the important questions[J].J Allergy Clin Immunol,2014,126(6):1337-1348.

    [6] 赵江,魏向平.特布他林气雾剂联合喘可治注射液治療52例支气管哮喘的临床疗效观察[J].中国医药指南,2014,12(13):138-139.

    [7] Paiva AC,Marson FA,Ribeiro JD,et al. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors[J]. Allergy Asthma Clin Immunol,2014,10(1):8.

    [8] Mishra A,Yao X,Levine SJ. From bedside to bench to clinic trials: identifying new treatments for severe asthma[J].Dis Models Mech,2013,6(4):877-888.

    (收稿日期:2017-06-02), 百拇医药(黄拔威 许能銮)
上一页1 2 3